Susquehanna International Group
HAE icon

Susquehanna International Group’s Haemonetics HAE Stock Holding History

Susquehanna International Group’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.77M Sell
66,900
-66,300
-50% -$4.32M ﹤0.01% 4791
2025
Q4 		$10.7M Sell
133,200
-10,900
-8% -$732K ﹤0.01% 2956
2025
Q3 		$7.02M Buy
144,100
+63,700
+79% +$3.94M ﹤0.01% 3561
2025
Q2 		$6M Sell
80,400
-30,600
-28% -$2.03M ﹤0.01% 3638
2025
Q1 		$7.05M Buy
111,000
+21,800
+24% +$1.48M ﹤0.01% 3024
2024
Q4 		$6.96M Sell
89,200
-91,200
-51% -$7.33M ﹤0.01% 3113
2024
Q3 		$14.5M Buy
180,400
+24,300
+16% +$1.96M ﹤0.01% 2155
2024
Q2 		$12.9M Buy
156,100
+111,700
+252% +$9.83M ﹤0.01% 2186
2024
Q1 		$3.79M Buy
44,400
+20,400
+85% +$1.6M ﹤0.01% 4103
2023
Q4 		$2.05M Buy
24,000
+8,100
+51% +$700K ﹤0.01% 5284
2023
Q3 		$1.42M Sell
15,900
-12,200
-43% -$1.09M ﹤0.01% 5848
2023
Q2 		$2.39M Buy
28,100
+5,900
+27% +$499K ﹤0.01% 4785
2023
Q1 		$1.84M Buy
22,200
+9,100
+69% +$737K ﹤0.01% 5317
2022
Q4 		$1.03M Sell
13,100
-11,600
-47% -$932K ﹤0.01% 6118
2022
Q3 		$1.83M Buy
24,700
+8,100
+49% +$582K ﹤0.01% 5099
2022
Q2 		$1.08M Sell
16,600
-6,400
-28% -$379K ﹤0.01% 6330
2022
Q1 		$1.45M Buy
23,000
+8,900
+63% +$484K ﹤0.01% 6218
2021
Q4 		$748K Sell
14,100
-59,700
-81% -$3.64M ﹤0.01% 8071
2021
Q3 		$5.21M Buy
73,800
+200
+0.3% +$12.6K ﹤0.01% 3874
2021
Q2 		$4.91M Buy
73,600
+59,400
+418% +$4.2M ﹤0.01% 4070
2021
Q1 		$1.58M Buy
14,200
+2,800
+25% +$346K ﹤0.01% 6501
2020
Q4 		$1.35M Sell
11,400
-34,000
-75% -$3.66M ﹤0.01% 5982
2020
Q3 		$3.96M Buy
45,400
+25,800
+132% +$2.25M ﹤0.01% 3386
2020
Q2 		$1.75M Sell
19,600
-66,500
-77% -$6.72M ﹤0.01% 4736
2020
Q1 		$8.58M Buy
86,100
+72,400
+528% +$7.85M ﹤0.01% 1914
2019
Q4 		$1.57M Sell
13,700
-28,200
-67% -$3.41M ﹤0.01% 4716
2019
Q3 		$5.29M Buy
41,900
+38,300
+1,064% +$4.86M ﹤0.01% 2649
2019
Q2 		$433K Sell
3,600
-6,600
-65% -$649K ﹤0.01% 7569
2019
Q1 		$892K Buy
10,200
+8,200
+410% +$746K ﹤0.01% 5241
2018
Q4 		$200K Sell
2,000
-6,800
-77% -$714K ﹤0.01% 7752
2018
Q3 		$1.01M Buy
+8,800
New +$911K ﹤0.01% 5195
2018
Q2 		– Sell
-6,800
Closed -$497K – 9906
2018
Q1 		$497K Buy
+6,800
New +$467K ﹤0.01% 6647
2016
Q4 		– Sell
-12,400
Closed -$449K – 9788
2016
Q3 		$449K Buy
12,400
+3,800
+44% +$130K ﹤0.01% 6269
2016
Q2 		$249K Buy
+8,600
New +$260K ﹤0.01% 7265
2014
Q2 		– Sell
-11,900
Closed -$388K – 9888
2014
Q1 		$388K Buy
+11,900
New +$455K ﹤0.01% 7177

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Susquehanna International Group's HAE Position: Q1 2026 in Review

Susquehanna International Group increased its Haemonetics (HAE) stake by 238% in Q1 2026, buying an estimated $10.7M and bringing the position to 234,271 shares worth $13.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2716.

Susquehanna International Group first reported a position in HAE in Q3 2013 and has held it in 41 quarters since. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Susquehanna International Group held 234,271 shares of Haemonetics worth $13.2M as of Q1 2026.
  • Susquehanna International Group bought 164,869 Haemonetics shares in Q1 2026, an estimated $10.7M.
  • Haemonetics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2716 holding.
  • Susquehanna International Group first reported a position in Haemonetics in Q3 2013 and has held it in 41 quarters since.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.